Heart Failure - Chronic Tài liệu tham khảo

Cập nhật: 11 June 2024
  1. Dickstein K, Cohen-Solal A, Filippatos G, et al; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008 Oct;29(19):2388-2442. doi: 10.1093/eurheartj/ehn309. PMID: 18799522
  2. Heart Failure Society of America, Lindelfeld J, Albert NM, et al. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010 Jun;16(6):e1-194. doi: 10.1016/j.cardfail.2010.04.004. PMID: 20610207
  3. McMurray JJ, Adamopoulos S, Anker SD, et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul;33(14):1787-1847. doi: 10.1093/eurheartj/ehs104. PMID: 22611136
  4. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep;112(12):e154-e235. http://circ.ahajournals.org/. PMID: 16160202
  5. Jessup M, Abraham WT, Casey DE, et al. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009 Apr;119(14):1977-2016. doi: 10.1161/CIRCULATIONAHA.109.192064. PMID: 19324967
  6. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157-163. doi: 10.1016/S0140-6736(03)15268-3. PMID: 14726171
  7. MedWormhttp://www.medworm.com/rss/index.php/Cardiology/7/http://www.medworm.com/rss/medicalfeeds/specialities/Cardiology.xml
  8. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  9. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Heart Foundation. http://www.heartfoundation.org.au. Oct 2011.
  10. MedWorm - Heart Failurehttp://www.medworm.com/rss/medicalfeeds/conditions/Heart-Failure-News.xml
  11. Writing Committee Members; Yancy CW, Jessup M, Bozkurt B, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Accessed 06 Apr 2015. PMID: 23741058
  12. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). Pedoman Tatalaksana Gagal Jantung. Edisi Pertama. Jakarta; 2015.
  13. DiNicolantonio JJ, Bhutani J, McCarty MF, et al. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart. 2015 Oct 19;2(1):e000326. doi: 10.1136/openhrt-2015-000326. Accessed 04 Apr 2016. PMID: 26512330
  14. Littarru GP. Ubiquinol, new insights into the most active form of Coenzyme Q10. France: Medicatrix; 2014:73, 108.
  15. Onur S, Niklowitz P, Jacobs G, et al. Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects (abstract). Biofactors. 2015 Jan-Feb;41(1):35-43. doi: 10.1002/biof.1198. Accessed 05 Apr 2016. PMID: 25728634
  16. Ministry of Health Malaysia, Academy of Medicine Malaysia, National Heart Association of Malaysia. Management of heart failure, 3rd edition clinical practice guideline 2014. Ministry of Health Malaysia. http://www.moh.gov.my. 2014.
  17. Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 Sep 27;68(13):1476-1488. doi: 10.1016/j.jacc.2016.05.011. Accessed 10 Jun 2016. PMID: 27216111
  18. Ponikowski P, Voors AA, Anker SD, et al; authors/task force members; document reviewers. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 May 20:1-85. doi: 10.1002/ejhf.592. Accessed 08 Jun 2016. PMID: 27207191
  19. Abarquez RF Jr, Reganit PF, Chungunco CN, et al. Chronic heart failure clinical practice guidelines' class 1-A pharmacologic recommendations: start-to-end synergistic drug therapy. ASEAN Heart J. 2016 Mar 8;24(1):4. doi: 10.7603/s40602-016-0004-5. Accessed 15 Jul 2016. PMID: 27054142
  20. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Accessed 09 Aug 2017. PMID: 28455343
  21. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Accessed 16 Nov 2017. PMID: 29146535
  22. Pirracchio R, Cholley B, De Hert S, et al. Diastolic heart failure in anaesthesia and critical care. Br J Anaesth. 2007 Jun;98(6):707-721. doi: 10.1093/bja/aem098. Accessed 04 Jul 2018. PMID: 17468492
  23. NHFA CSANZ Heart Failure Working Group, Atherton JJ, Sindone A, Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ. 2018 Oct;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042. Accessed 21 Mar 2019. PMID: 30077227
  24. National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management. NICE. http://www.nice.org.uk. Sep 2018. Accessed 21 Mar 2019.
  25. Academy of Medicine Malaysia, Ministry of Health Malaysia, National Heart Association of Malaysia. Clinical practice guidelines management of heart failure 2019. 4th ed. National Heart Association of Malaysia. https://www.malaysianheart.org. 04 Sep 2019. Accessed 10 Sep 2019.
  26. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425. Accessed 10 Sep 2019. PMID: 31504439
  27. Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 Oct;21(10):1169-1186. doi: 10.1002/ejhf.1531. Accessed 02 Oct 2019. PMID: 31129923
  28. van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019 Jun 04;73(21):2756-2768. doi: 10.1016/j.jacc.2019.03.478. Accessed 02 Oct 2019. PMID: 31146820
  29. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391. PMID: 28886619
  30. Writing Committee; Maddox TM, Januzzi Jr JL, Allen LA, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Jan 04;S0735-1097(20)37867-0. doi: 10.1016/j.jacc.2020.11.022. PMID: 33446410
  31. Kuin BKW, Yee OH, Ping CLS, et al. 2020 Clinical practice guidelines on the diagnosis and management of heart failure - a comprehensive updated guideline from the Heart Failure Society (Singapore). Heart Failure Society (Singapore). https://www.hfss.org.sg. 2020. Accessed 27 Jan 2021.
  32. The European Society for Cardiology (ESC). ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. ESC. https://www.escardio.org. 10 Jun 2020. Accessed 22 Feb 2021.
  33. Tsutsui H, Isobe J, Ito H, et al. JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure - digest version. Circ J. 2019 Sep 25;83(10):2084-2184. doi: 10.1253/circj.CJ-19-0342. PMID: 31511439
  34. Bozkurt B, Hershberger RE, Butler J, et al. 2021 ACC/AHA key data elements and definitions for heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). J Am Coll Cardiol. 2021 Apr 27;77(16):2053-2150. doi: 10.1016/j.jacc.2020.11.012. PMID: 33250265
  35. NHS. Alcohol units. NHS. https://www.nhs.uk. 13 Apr 2018.
  36. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Accessed 15 Dec 2021. PMID: 34447992
  37. Visseren FLJ, Mach F, Smulders YM, et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Accessed 15 Dec 2021. PMID: 34458905
  38. American Diabetes Association. Standards of medical care in diabetes - 2020. Diabetes Care. 2020 Jan;43(Suppl 1):S1-S212. https://care.diabetesjournals.org. Accessed 06 Jan 2020
  39. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. PMID: 35363499
  40. The Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-1103. doi: 10.1093/eurheartj/ehab697. Accessed 28 May 2022. PMID: 34791154
  41. Ariyachaipanich A, Buakhamsri A, Phrommintikul A, et al. 2022 HFCT focused update of the 2019 HFCT heart failure guidelines: part 1 – heart failure classification and pharmacological treatment for heart failure with reduced ejection fraction (HFrEF). J Med Assoc Thai. 2022;105(11):1153-1159. doi: 10.35755/medassocthai.2022.11.13702. Accessed 12 Mar 2023
  42. Borlaug BA. Pathophysiology of heart failure with preserved ejection fraction. UpToDate. https://www.uptodate.com. 22 Oct 2021.
  43. Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115.
  44. Colucci WS, Borlaug BA. Heart failure: clinical manifestations and diagnosis in adults. UpToDate. https://www.uptodate.com. 20 Apr 2022.
  45. Colucci WS. Pathophysiology of heart failure with reduced ejection fraction: hemodynamic alterations and remodeling. UpToDate. https://www.uptodate.com. 11 Aug 2022.
  46. National Institute for Care and Excellence (NICE). Chronic heart failure in adults. NICE. https://www.nice.org.uk/. 10 Jan 2023. Accessed 14 Jan 2023.
  47. Schwinger RHG. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021 Feb;11(1):263-276. doi: 10.2017/cdt-20-302. PMID: 33708498
  48. Vasan RS, Wilson PWF. Epidemiology of heart failure. UpToDate. https://www.uptodate.com. 23 Nov 2022.
  49. AstraZeneca. Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients. AstraZeneca. https://www.astrazeneca.com. 09 May 2023.
  50. Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. PMID: 37137593
  51. Inpefa highlights of prescribing information. GlobeNewswire. https://www.lexpharma.com. May 2023.
  52. Lexicon Pharmaceuticals. Lexicon announces FDA approval of Inpefa (sotagliflozin) for treatment of heart failure. GlobeNewswire. https://www.globenewswire.com. 26 May 2023.
  53. Marx N, Federici M, Schutt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Aug 25;ehad192. doi: 10.1093/eurheartj/ehad192. Accessed 04 Sep 2023. PMID: 37622663
  54. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Aug 25;ehad195. doi: 10.1093/eurheartj/ehad195. PMID: 37622666
  55. Heart Failure Clinical Practice Guideline Task Force 2023. Philippine clinical practice guidelines on the diagnosis and management of chronic heart failure with reduced ejection fraction for primary care physicians. Department of Health Philippines. https://doh.gov.ph. 2023.
  56. Writing Committee; Maddox TM, Januzzi Jr JL, Allen LA, et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Mar 2;S0735-1097(23):08354-7. doi: 10.1016/j.jacc.2023.12.024. PMID: 38466244